{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:40:57Z","timestamp":1648849257517},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00063-013-0318-z","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T14:38:44Z","timestamp":1384267124000},"page":"683-696","source":"Crossref","is-referenced-by-count":3,"title":["Psychopharmakotherapie im Notarztdienst"],"prefix":"10.1007","volume":"108","author":[{"given":"A.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.-G.B.","family":"Pajonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"318_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10049-013-1699-5","volume":"16","author":"Wolf","year":"2013","unstructured":"Wolf A, M\u00fcller MJ, Pajonk FG (2013) Psychopharmaka im Notarztdienst. Notfall Rettungsmed 16:397\u2013407","journal-title":"Notfall Rettungsmed"},{"key":"318_CR2","doi-asserted-by":"crossref","unstructured":"M\u00fcller MJ, Lange-Asschenfeldt C (2012) Pharmakotherapie psychiatrischer Notfallsituationen. In: Gr\u00fcnder G, Benkert O (Hrsg) Handbuch der Psychopharmakotherapie. Springer, Berlin Heidelberg New York Tokio, S\u00a01123\u20131135","DOI":"10.1007\/978-3-642-19844-1_87"},{"key":"318_CR3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00063-012-0123-0","volume":"107","author":"Fl\u00fcchter","year":"2012","unstructured":"Fl\u00fcchter P, M\u00fcller V, Pajonk FG (2012) Suizidalit\u00e4t: Procedere im Notfall. Med Klin Intensivmed Notfallmed 107(6):469\u2013475","journal-title":"Med Klin Intensivmed Notfallmed"},{"key":"318_CR4","unstructured":"Deutsche Gesellschaft f\u00fcr Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) (2010) Therapeutische Ma\u00dfnahmen bei aggressivem Verhalten in der Psychiatrie und Psychotherapie. AWMF-Leitlinienregisternummer 038\/022. AWMF, D\u00fcsseldorf. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/038-022_S2_Therapeutische_Massnahmen_bei_aggressivem_Verhalten_in_der_Psychiatrie_und_Psychotherapie_lang_08-2009_08-2014.pdf. Zugegriffen: 01.07.2013"},{"key":"318_CR5","doi-asserted-by":"crossref","unstructured":"Benkert O, Hippius H (2010) Kompendium der psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg New York Tokio","DOI":"10.1007\/978-3-642-13044-1"},{"key":"318_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eurpsy.2004.05.006","volume":"19","author":"De","year":"2004","unstructured":"De Fruyt J, Demyttenaere K (2004) Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbances. Eur Psychiatry 19:243\u2013249","journal-title":"Eur Psychiatry"},{"key":"318_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","volume":"13","author":"Wilson","year":"2012","unstructured":"Wilson MP, Pepper D, Currier GW et al (2012) The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project Beta Psychopharmacology Workgroup. West J Emerg Med 13:26\u201334","journal-title":"West J Emerg Med"},{"key":"318_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","volume":"59","author":"Breier","year":"2002","unstructured":"Breier A, Meehan K, Birkett M et al (2002) A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59:441\u2013448","journal-title":"Arch Gen Psychiatry"},{"key":"318_CR9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4088\/JCP.v67n0415","volume":"67","author":"Citrome","year":"2006","unstructured":"Citrome L, Volavka J, Czobor P et al (2006) Efficacy of ziprasidone against hostility in schizophrenia: post hoc analysis of randomized, open-label study data. J Clin Psychiatry 67:638\u2013642","journal-title":"J Clin Psychiatry"},{"key":"318_CR10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","volume":"158","author":"Wright","year":"2001","unstructured":"Wright P, Birkett M, David SR et al (2001) Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158:1149\u20131151","journal-title":"Am J Psychiatry"},{"key":"318_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0735-6757(97)90119-4","volume":"15","author":"Battaglia","year":"1997","unstructured":"Battaglia J, Moss S, Rush J et al (1997) Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 15:335\u2013340","journal-title":"Am J Emerg Med"},{"key":"318_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/j.1875-9114.1998.tb03827.x","volume":"18","author":"Bieniek","year":"1998","unstructured":"Bieniek SA, Ownby RL, Penalver A et al (1998) A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 18:57\u201362","journal-title":"Pharmacotherapy"},{"key":"318_CR13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/ajp.156.1.142","volume":"156","author":"Dorevitch","year":"1999","unstructured":"Dorevitch A, Katz N, Zemishlany Z et al (1999) Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. Am J Psychiatry 156:142\u2013144","journal-title":"Am J Psychiatry"},{"key":"318_CR14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004850-199705000-00009","volume":"12","author":"Foster","year":"1997","unstructured":"Foster S, Kessel J, Berman ME et al (1997) Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. Int Clin Psychopharmacol 12:175\u2013179","journal-title":"Int Clin Psychopharmacol"},{"key":"318_CR15","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1176\/ajp.146.12.1598","volume":"146","author":"Garza-Trevino","year":"1989","unstructured":"Garza-Trevino ES, Hollister LE, Overall JE et al (1989) Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. Am J Psychiatry 146:1598\u20131601","journal-title":"Am J Psychiatry"},{"key":"318_CR16","first-page":"126","volume":"26","author":"Wyant","year":"1990","unstructured":"Wyant M, Diamond BI, O\u2019neal E et al (1990) The use of midazolam in acutely agitated psychiatric patients. Psychopharmacol Bull 26:126\u2013129","journal-title":"Psychopharmacol Bull"},{"key":"318_CR17","first-page":"CD005146","volume":"1","author":"Huf","year":"2005","unstructured":"Huf G, Alexander J, Allen MH (2005) Haloperidol plus promethazine for psychosis induced aggression. Cochrane Database Syst Rev 1:CD005146","journal-title":"Cochrane Database Syst Rev"},{"key":"318_CR18","first-page":"CD005146","volume":"3","author":"Huf","year":"2009","unstructured":"Huf G, Alexander J, Allen MH et al (2009) Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev 3:CD005146","journal-title":"Cochrane Database Syst Rev"},{"key":"318_CR19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.4088\/JCP.v69n1204","volume":"69","author":"Satterthwaite","year":"2008","unstructured":"Satterthwaite TD, Wolf DH, Rosenheck RA et al (2008) A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. J Clin Psychiatry 69:1869\u20131879","journal-title":"J Clin Psychiatry"},{"key":"318_CR20","first-page":"294","volume":"47","author":"Dubin","year":"1986","unstructured":"Dubin WR, Weiss KJ (1986) Rapid tranquilization: a comparison of thiothixene with loxapine. J Clin Psychiatry 47:294\u2013297","journal-title":"J Clin Psychiatry"},{"key":"318_CR21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4088\/JCP.10m06011yel","volume":"72","author":"Allen","year":"2011","unstructured":"Allen MH, Feifel D, Lesem MD et al (2011) Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 72:1313\u20131321","journal-title":"J Clin Psychiatry"},{"key":"318_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-5618.2011.00975.x","volume":"14","author":"Kwentus","year":"2012","unstructured":"Kwentus J, Riesenberg RA, Marandi M et al (2012) Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Bipolar Disord 14:31\u201340","journal-title":"Bipolar Disord"},{"key":"318_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1192\/bjp.bp.110.081513","volume":"198","author":"Lesem","year":"2011","unstructured":"Lesem MD, Tran-Johnson TK, Riesenberg RA et al (2011) Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br J Psychiatry 198:51\u201358","journal-title":"Br J Psychiatry"},{"key":"318_CR24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1742-1241.2010.02615.x","volume":"65","author":"Citrome","year":"2011","unstructured":"Citrome L (2011) Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder. Int J Clin Pract 65:330\u2013340","journal-title":"Int J Clin Pract"},{"key":"318_CR25","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.4088\/JCP.v68n1207","volume":"68","author":"Citrome","year":"2007","unstructured":"Citrome L (2007) Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry 68:1876\u20131885","journal-title":"J Clin Psychiatry"},{"key":"318_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.pra.0000271657.09717.e2","volume":"13","author":"Currier","year":"2007","unstructured":"Currier GW, Citrome LL, Zimbroff DL et al (2007) Intramuscular aripiprazole in the control of agitation. J Psychiatr Pract 13:159\u2013169","journal-title":"J Psychiatr Pract"},{"key":"318_CR27","first-page":"CD003729","volume":"2","author":"Belgamwar","year":"2005","unstructured":"Belgamwar RB, Fenton M (2005) Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses. Cochrane Database Syst Rev 2:CD003729","journal-title":"Cochrane Database Syst Rev"},{"key":"318_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","volume":"185","author":"Alexander","year":"2004","unstructured":"Alexander J, Tharyan P, Adams C et al (2004) Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry 185:63\u201369","journal-title":"Br J Psychiatry"},{"key":"318_CR29","first-page":"CD003079","volume":"4","author":"Gillies","year":"2005","unstructured":"Gillies D, Beck A, Mccloud A et al (2005) Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst Rev 4:CD003079","journal-title":"Cochrane Database Syst Rev"},{"key":"318_CR30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/appi.ajp.2009.09050703","volume":"167","author":"Zisselman","year":"2010","unstructured":"Zisselman MH, Jaffe RL (2010) ECT in the treatment of a patient with catatonia: consent and complications. Am J Psychiatry 167:127\u2013132","journal-title":"Am J Psychiatry"},{"key":"318_CR31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0006-3223(98)00312-6","volume":"46","author":"Schmider","year":"1999","unstructured":"Schmider J, Standhart H, Deuschle M et al (1999) A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biol Psychiatry 46:437\u2013441","journal-title":"Biol Psychiatry"},{"key":"318_CR32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-2007-1017023","volume":"21","author":"Wetzel","year":"1988","unstructured":"Wetzel H, Heuser I, Benkert O (1988) Benzodiazepines for catatonic symptoms, stupor, and mutism. Pharmacopsychiatry 21:394\u2013395","journal-title":"Pharmacopsychiatry"},{"key":"318_CR33","first-page":"66","volume":"8","author":"Aboraya","year":"2009","unstructured":"Aboraya A, Chumber P, Altaha B (2009) The treatment resistant catatonic patient. Curr Psychiatr 8:66\u201369","journal-title":"Curr Psychiatr"},{"key":"318_CR34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1176\/appi.psy.48.6.534","volume":"48","author":"Babington","year":"2007","unstructured":"Babington PW, Spiegel DR (2007) Treatment of catatonia with olanzapine and amantadine. Psychosomatics 48:534\u2013536","journal-title":"Psychosomatics"},{"key":"318_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3371\/CSRP.4.3.5","volume":"4","author":"Kirino","year":"2010","unstructured":"Kirino E (2010) Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report. Clin Schizophr Relat Psychoses 4:185\u2013188","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"318_CR36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2009.12.023","volume":"118","author":"Peralta","year":"2010","unstructured":"Peralta V, Campos MS, De Jalon EG et al (2010) DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Schizophr Res 118:168\u2013175","journal-title":"Schizophr Res"},{"key":"318_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00115-005-1966-x","volume":"77","author":"Haverkamp","year":"2006","unstructured":"Haverkamp W, Deuschle M (2006) Antipsychotikainduzierte QT-Verlangerung. Nervenarzt 77:276, 278\u2013280, 282\u2013274","journal-title":"Nervenarzt"},{"key":"318_CR38","unstructured":"JANSSEN-CILAG GmbH, Neuss (Stand Dezember 2011) Fachinformation Haldol\u00ae-Janssen Injektionsl\u00f6sung 5\u00a0mg\/ml. http:\/\/www.fachinfo.de. Zugegriffen 01.07.2013"},{"key":"318_CR39","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (2010) Drug Safety Mail 2010-098 vom 05.05.2010. Arzneimittelkommission der deutschen \u00c4rzteschaft, Berlin"},{"key":"318_CR40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00101-012-1980-x","volume":"61","author":"Biedler","year":"2012","unstructured":"Biedler A, Helfen C, Pajonk FG (2012) Behandlungsbed\u00fcrftigkeit psychiatrischer Notf\u00e4lle im Notarztdienst. Evaluierung des \u201eIndikator f\u00fcr psychiatrische Pharmakotherapie\u201c. Anaesthesist 61:116\u2013122","journal-title":"Anaesthesist"},{"key":"318_CR41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10049-004-0689-z","volume":"7","author":"Tonn","year":"2004","unstructured":"Tonn P, Reuter S, Treder B et al (2004) Die pr\u00e4klinische Behandlung von akut erregten, deliranten oder psychotischen Patienten durch den Notarzt. Notfall Rettungsmed 7:484\u2013492","journal-title":"Notfall Rettungsmed"},{"key":"318_CR42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/106002809603000517","volume":"30","author":"Brown","year":"1996","unstructured":"Brown TM, Skop BP, Mareth TR (1996) Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 30:527\u2013533","journal-title":"Ann Pharmacother"},{"key":"318_CR43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjopharm.2005.09.014","volume":"3","author":"Kotlyar","year":"2005","unstructured":"Kotlyar M, Dysken M, Adson DE (2005) Update on drug-induced depression in the elderly. Am J Geriatr Pharmacother 3:288\u2013300","journal-title":"Am J Geriatr Pharmacother"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-013-0318-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0318-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T03:28:27Z","timestamp":1647055707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-013-0318-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1007\/s00063-013-0318-z","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}